beta-Lactamase inhibitors and the inducibility of the beta-lactamase of Mycobacterium tuberculosis.

Ten clinical isolates and the type strain (H37Rv) of Mycobacterium tuberculosis were shown to produce an intracellular beta-lactamase. Crude enzyme preparations were extracted from acetone cell powders by grinding with zirconium beads in 0.133 M glycine with 1.0% Triton X-100. The enzymes had identical patterns on isoelectric focusing, with two major bands at isoelectric points of 4.9 and 5.1. The beta-lactamase was highly susceptible to the new beta-lactamase inhibitor BRL 42715, with an I50 of 0.0001 microgram/ml. The enzyme was also susceptible to clavulanic acid with an I50 (0.05 microgram/ml), which was similar to the value for the common bacterial beta-lactamase TEM-1 (0.01 microgram/ml). The latter result is consistent with previous MIC studies with M. tuberculosis, which have shown synergy between clavulanic acid and amoxicillin. BRL 42715 and clavulanic acid were more active than sulbactam, tazobactam, and cloxacillin. These studies support the potential value of penicillin/clavulanic acid and penicillin/BRL 42715 combinations in the treatment of tuberculosis.

[1]  J. Kasík,et al.  The effect of the penicillinase-resistant penicillins and other chemotherapeutic substances on the penicillinase of the R1Rv strain of Mycobacterium tuberculosis. , 1967, The American review of respiratory disease.

[2]  R. Wallace,,et al.  Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid , 1991, Antimicrobial Agents and Chemotherapy.

[3]  E. Abraham,et al.  Synergistic Action of Penicillins and Cephalosporins Against Pseudomonas pyocyanea , 1964, Nature.

[4]  R. Wallace,,et al.  Isoelectric focusing of beta-lactamases in Mycobacterium fortuitum. Association of a single enzyme pattern with cefoxitin resistance. , 1985, The American review of respiratory disease.

[5]  M. Cynamon,et al.  In-vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium kansasii to amoxycillin and ticarcillin in combination with clavulanic acid. , 1988, The Journal of antimicrobial chemotherapy.

[6]  H. Spiro,et al.  Tocopherol deficiency in man. , 1965, The New England journal of medicine.

[7]  M. C. Román,et al.  Preliminary investigation of Mycobacterium tuberculosis biovars , 1984, Journal of clinical microbiology.

[8]  E. Abraham,et al.  Penicillin-methicillin synergism , 1965 .

[9]  W. Barclay,et al.  The synergistic effect of dicloxacillin and penicillin G on murine tuberculosis. , 1966, The American review of respiratory disease.

[10]  M. Casal,et al.  In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae to ticarcillin in combination with clavulanic acid , 1987, Antimicrobial Agents and Chemotherapy.

[11]  Howard Florey,et al.  FURTHER OBSERVATIONS ON PENICILLIN , 1941 .

[12]  M. A. Soltys.  The effect of penicillin on Mycobacteria in vitro and in vivo. , 1952, Tubercle.

[13]  Kubica Gp,et al.  Fluorescent antibody techniques with mycobacteria. 3. Investigation of five serologically homogenous groups of mycobacteria. , 1968 .

[14]  J. Berger,et al.  Amoxicillin-clavulanic acid for treating drug-resistant Mycobacterium tuberculosis. , 1991, Chest.

[15]  Karlson Ag,et al.  Streptomycin sensitivity of tubercle bacilli; studies on recently isolated tubercle bacilli and the development of resistance to streptomycin in vivo. , 1947 .

[16]  R. Villalba,et al.  In vitro activity of antimicrobial agents against mycobacteria. , 1988, Drugs under experimental and clinical research.

[17]  N. Thompson,et al.  Bacteriophage types of Mycobacterium tuberculosis in the United States. , 2015, The American review of respiratory disease.

[18]  M. Cynamon,et al.  In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosis , 1983, Antimicrobial Agents and Chemotherapy.

[19]  M. Cynamon,et al.  Comparison of four β-lactamase inhibitors in combination with ampicillin against Mycobacterium tuberculosis , 1987 .